Delivery Order SPE2DB22D2211-SPE2DB24FMSP4
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a completion date of February 6, 2024 and a potential value of $4,317.70. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not part of a larger contract vehicle. No set-aside designation was used for this award. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The total potential value of this order is $3,210.65, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $2,565.78 firm fixed-price contract has a completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,609.30 contract is for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 2025....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $1,673.60 firm-fixed-price contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical product. The $4,757.95 contract has a completion date of March 20, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is supplying the pharmaceutical product to support military treatment programs and facilities. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 0.5 ML PEDIARIX syringes. The $10,292.64 contract has a completion date of February 26, 2024 and supports military treatment programs and facilities. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide PEDIARIX 0.5ML syringes. The $15,902.20 delivery order has a completion date of February 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,323.40 to Amerisourcebergen Drug Corp for the supply of 0.5 mL PEDIARIX vaccine syringes. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,156.26. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, with a completion date of February 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMSP4Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a potential value of $7,290.30 and a completion date of February 1, 2024. This award is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 5/1/24, 10:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 1/31/24 |